Mobilization with Movement for people with rotator cuff lesions
Official title: The Effect of Mobilization With Movement on Function, Disability, and Pain in Patients With Rotator Cuff Lesions: A Double-Blind Randomized Controlled Trial
Run by Kirsehir Ahi Evran Universitesi · NCT07383038 · Data updated 2026-11-12
This trial will test whether Mobilization with Movement helps reduce pain, improve shoulder function, and restore joint position sense in adults with rotator cuff lesions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | Kirsehir Ahi Evran Universitesi Academic / other |
| Locations | 1 site (Kırşehir) |
| Status | Recruiting |
| Started | August 25, 2025 |
| Main results expected | August 25, 2026 |
| Study ends | August 28, 2026 |
| Registry record updated | June 8, 2026 |
| Trial ID | NCT07383038 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with clinical or imaging evidence of rotator cuff tendinopathy or partial tear, at least three months of shoulder pain and movement-related functional limitation, and the ability to actively perform the shoulder movements required for assessment are the intended candidates.
✕Probably not a fit
People with full-thickness rotator cuff tears, prior shoulder surgery, recent shoulder fracture/dislocation or acute trauma, shoulder instability, severe osteoarthritis or adhesive capsulitis, neurological disorders affecting the upper limb, or recent corticosteroid injection are excluded and unlikely to benefit from the interventions tested here.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial will randomly assign eligible adults with clinically or imaging-confirmed rotator cuff lesions and chronic shoulder pain to one of three groups: Mulligan Mobilization with Movement (MWM), conventional physiotherapy, or a control group. Interventions are delivered by physiotherapists and participants are evaluated before and after the intervention period using the QuickDASH for shoulder-related disability, pain intensity measures, and an active shoulder repositioning test with a laser pointer to quantify joint position sense. The protocol excludes full-thickness tears, prior shoulder surgery, recent acute trauma, significant neurological or rheumatologic disease, severe osteoarthritis or adhesive capsulitis, and recent corticosteroid injection or manual therapy. The trial is designed to determine whether MWM provides additional benefits in pain, function, or proprioception beyond conventional care or no intervention.
Why it matters
Potential benefit: If successful, MWM could provide greater pain relief, improved shoulder function, and better joint position sense compared with conventional physiotherapy or no intervention.
How similar studies have gone: Prior studies have shown MWM can reduce pain and improve function in various musculoskeletal conditions, but evidence is limited specifically regarding its effects on shoulder proprioception in rotator cuff lesions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 65 years * Clinical and/or imaging-confirmed diagnosis of rotator cuff lesion (e.g., tendinopathy or partial tear) * Presence of shoulder pain for at least 3 months * Pain and functional limitation during shoulder movements * Ability to actively perform shoulder movements required for assessment and intervention * No physiotherapy or manual therapy treatment for the affected shoulder within the last 3 months Exclusion Criteria: * History of shoulder surgery on the affected side * Full-thickness rotator cuff tear or shoulder instability * Shoulder fracture, dislocation, or acute trauma within the past 6 months * Neurological disorders affecting the upper extremity (e.g., cervical radiculopathy, peripheral neuropathy) * Systemic inflammatory or rheumatologic diseases * Severe shoulder osteoarthritis or adhesive capsulitis * Current participation in another clinical trial * Use of corticosteroid injection in the affected shoulder within the last 3 months * Pregnancy * Inability to comply with the study protocol or assessment procedures
Where it's running
-
Ahi Evran University
Kırşehir, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Ömer Faruk Özçelep, PhD
- Email: omer.ozcelep@ahievran.edu.tr
- Phone: +90 531 946 3777
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotator cuff repair with biceps rerouting and dermal graft augmentation for large, difficult tears
This study tests a combined surgical approach to see if it helps tendon retear rates in adults with large rotator cuff tears that are hard to repair.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
-
Biomarkers to see if rotator cuff repairs will heal after surgery
This study tests whether biomarkers in shoulder tissue and synovial fluid can predict whether a rotator cuff repair will heal, using MRI after surgery to compare those who heal with those who don’t.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
-
Frame Running to Improve Exercise and Participation for Children and Young People With Physical Disabilities
This project will try a 24-week Frame Running training program to see if it improves function, participation, and quality of life in 8–18-year-olds with cerebral palsy or other physical disabilities.
-
Self-compassion and self-efficacy in Parkinson’s disease and physical disability
Researchers will see if higher self-compassion and self-efficacy relate to fewer symptoms, better function, and improved quality of life in people with Parkinson’s disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.